Specially designed rig will act as crash pad for truckers while construction closes runaway ramps – CDLLife

Truckers who lose control at the bottom of a freeway in Australia are expected to crash into the back of a specially designed truck for the duration of construction, officials say.

The South Eastern Freeway will be under construction for resurfacing beginning this upcoming Sunday, which will close the runaway truck ramps. Because of this, the Transport Department has set up a special truck outfitted with a shock absorber system as a replacement for the ramps.

It is basically a rigid truck with a massive rear fender with a huge shock absorber system built into it, said The head of the South Australian Road Transport Association, Steve Shearer.

Apparently it can withstand the impact of a fully loaded semi-trailer going at 100kmph, it will stop that truck.

While the device is structurally sound, officials say the trickiest part of this transition will be getting truck drivers to actually use the device, since they spend so much of their lives trying not to smash into another truck.

Its a very innovative, but mentally challenging approach, Shearer said to ABC News Australia.

Its been used elsewhere in the country and on some roadworks with lower speed events to protect the road workers, but the point weve made is its counter-intuitive for a truck driver. The human behavior problem is getting truck drivers to understand what theyre seeing in front of them.

Would you be able to intentionally crash into this truck if your brakes failed?

See the article here:
Specially designed rig will act as crash pad for truckers while construction closes runaway ramps - CDLLife

Biochemistry, Doppler echocardiography, and electrocardiography evaluation in captive owl monkeys (Aotus sp). – Physician’s Weekly

The cardiovascular system of owl monkeys has been studied due to frequent postmortem findings of heart disease in asymptomatic animals. The silent aspect and the difficulty of early diagnosis intensify the importance of studying the cardiovascular system in this species.Echocardiogram evaluation was carried out on 60 animals, grouped into suspect or non-suspect of having heart diseases, and evaluated through electrocardiogram, hematology, and biochemical tests.Doppler echocardiography indicated two animals with suspicion of left ventricular hypertrophy and eight with dilated cardiomyopathy. Suspect animals had higher cardiac measurements and reduced shortening fraction. Troponin I was detectable in two animals (0.128ng/mL and 0.584ng/mL), and serum albumin concentration was significantly higher in non-suspect animals (P<.05).The importance of echocardiographic measurements of IVSd, IVSs, LVIDd, LVIDs, LVPWd, LVPWs, LA, EF, and FS in the cardiac evaluation of captive owl monkeys was evidenced.

PubMed

Here is the original post:
Biochemistry, Doppler echocardiography, and electrocardiography evaluation in captive owl monkeys (Aotus sp). - Physician's Weekly

Student Scientist Searches for Therapeutics to Treat West Nile Virus | CSUF News – CSUF News

Biochemistry major Shaina Nguyen works in the lab on her West Nile virus research project.

With no treatment or cure for West Nile virus spread through the bite of an infected mosquito Cal State Fullerton undergraduate researcher Shaina Nguyen is working on creating new therapeutics to treat people infected with the disease.

Hopefully, our research could provide possible drug therapeutics to stop West Nile virus, Nguyen said.

Since her freshman year, Nguyen, a biochemistry major who is graduating in May, has worked in the lab of Nicholas T. Salzameda, associate professor of chemistry and biochemistry. The researchers are seeking treatments since there is no vaccine or medications available for the mosquito-borne disease.

In the ongoing study, the faculty-student research team is studying a viral protein for the West Nile virus, known as the NS2B-NS3 protease, which is responsible for producing viral particles for replication and is a promising therapeutic target in stopping infection, Nguyen said.

The lab also is experimenting with Zafirlukast, a currently available anti-asthmatic drug.

Given the structure of Zafirlukast, we want to make modifications to this drug to see if it could further improve the inhibition against the West Nile virus NS2B-NS3 protease, she said.

According to the Centers for Disease Control and Prevention, during mosquito season, which starts in the summer and continues through fall, about 1 in 5 people who are infected with West Nile virus develop a fever and other symptoms. About 1 out of 150 infected people get a severe condition, including neurological symptoms, such as meningitis and encephalitis, or sometimes, fatal illnesses.

Glenn Nagel Undergraduate Student Research Award

For her outstanding research and presentation, Nguyen received the Glenn Nagel Undergraduate Student Research Award at the recent 33rd annual California State University Biotechnology Symposium. The award is named in honor of Nagel, a former biochemistry professor at Cal State Fullerton who became a dean at Cal State Long Beach. The Nagel Award fosters excellence in undergraduate student research.

The virtual symposium, presented by the California State University Program for Education and Research in Biotechnology, featured 36 student nominees and finalists from 13 campuses who competed for systemwide undergraduate and graduate research awards.

Its humbling to receive this award. Dr. Salzameda has pushed me and guided me to realize my dreams for graduate school, said Nguyen, an award-winning scholar who has presented her research at regional and national conferences.

Nguyen is a scholar in the universitys Maximizing Access to Research Careers (MARC) program, which prepares students for graduate school and careers in biomedical research, a Presidents Scholar and University Honors Program student.

Her research adviser relayed that Nguyen, who plans to pursue an M.D.-Ph.D. program to become a physician-scientist in a clinical setting, is a top student scholar.

Shaina has always found ways to amaze me, whether earning As in all her courses or making a new molecule that others could not make, Salzameda said. The M.D.-Ph.D. programs are reserved for the very best students. Shaina will succeed and put her talents to improving the health care of people through biomedical research.

Nguyens parents, who were teenagers, and grandparents fled Vietnam in the late 1970s. Her close family ties reinforce the importance of holding on to her Vietnamese culture and her academic pursuits and career goals.

She has maintained a 4.0 GPA, despite the personal loss of both her grandmothers while in college. Nguyen pressed on by spending long hours in the lab several days a week to work on her research project, earning good grades and staying on track to graduate in four years.

My grandmothers wouldnt have wanted me to stop, Nguyen said. This research project has required a lot of hard work, with bumps along the way, but it has paid off.

Go here to read the rest:
Student Scientist Searches for Therapeutics to Treat West Nile Virus | CSUF News - CSUF News

Bio-Based Itaconic Acid Market 2021 | Key Findings, Trends, Market Share, and Growth Forecast | Thermo Fisher Scientific., Itaconix Corporation,…

Report Overview:

Bio-Based Itaconic Acid Market research report is a scrupulous investigation of current scenario of the market which covers several market dynamics.The report Giveswide-ranging industry information which explores practical growth strategies and recommendations related toBio-Based Itaconic Acid industry.ThemarketReport provides key information about theBio-Based Itaconic Acid industry such as helpful and important facts and figures, expert opinions, and the latest developments across the globe

Scope of The Report:

Bio-Based Itaconic Acid Market Reportdefine, segment, and forecast the size of theBio-Based Itaconic AcidIndustry with respect to type, application and region.Report Helps to understand market conditions, company ranking, market structure, growth drivers.Report Provides historical data and forecast the data of the Key market segments.Bio-Based Itaconic AcidMarket Report also gives detailed information about the crucial factors that are influencing the growth of the market (drivers, restraints, opportunities, and challenges)and provide details of the competitive landscape for market leaderswhich showsthe opportunities in the market.

Download Free PDF Sample Report @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-bio-based-itaconic-acid-market

Bio-Based Itaconic Acid Market ReportProvidesdetail market insightConsidering current scenario of Market which includes definition,trends, competitive analysis,market segmentation.Report covers the different market scenarios that have direct impact on the growth of the market.

MarketInsight:

Bio-based itaconic acid market is expected to grow at a rate of 5.50% for the forecast period of 2020 to 2027. Data Bridge Market Research report on bio-based itaconic acid market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecasted period while providing their impacts on the markets growth.The changing trend towards eco-friendly products due to growing awareness regarding green house emissions will help impact the bio-based itaconic acid market growth in the forecast period.

Analysis of Key Vendors:

The major players covered in the bio-based itaconic acid market report are Thermo Fisher Scientific., Itaconix Corporation, Qingdao Kehai Biochemistry Co., LTD., AEKYUNG PETROCHEMICAL Co., Ltd, Zhejiang Guoguang Biochemistry Co.,Ltd., Spectrum Ultimate Chem India Pvt. Ltd, Alpha Chemika, Haihang Industry Co., Ltd, Ronas Chemicals Ind. Co., Ltd., Hefei TNJ Chemical Industry Co.,Ltd., Alfa Aesar, Merck KGaA, Choice Organochem Llp., FUSO CHEMICAL CO., LTD., Henan Haofei Chemical Co.,Ltd., Chemical Manufacturing Corp and FUJIFILM Wako Pure Chemical Corporation, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

For Any Enquiry or Specific Requirement Speak to Our Analyst @https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-bio-based-itaconic-acid-market

TheBio-Based Itaconic Acid MarketReport is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis.The market report covers strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. It also delivers the list of leading competitors and provides the insights about strategic analysis of the key factors influencing the Bio-Based Itaconic Acid industry.This report has been prepared by considering various steps for collecting, recording and analysing market data whichdirects the manufacturer about planning of advertising and sales promotion efforts and makes it more effective.

Key Points from Table of Content:

Chapter 1: Bio-Based Itaconic Acid Introduction and Market Overview1.1 Objectives of the Study1.2 Overview ofBio-Based Itaconic Acid1.3 Scope of The Study1.3.1 Key Market Segments1.3.2 Players Covered1.3.3 COVID-19s impact on the Bio-Based Itaconic Acid industry1.4 Methodology of The Study1.5 Research Data Source

Chapter 2: Market Dynamics2.1 DROC2.1.1 Drivers2.1.2 Restraints2.1.3 Opportunities2.1.4 Challenges2.2 PEST Analysis2.2.1 Political2.2.2 Economic2.2.3 Social2.2.4 Technological2.3 Market Impacting Trends2.4 Porters 5-force Analysis

Chapter 3: Segmentation & Statistics3.1 Segmentation Overview3.2 Demand Forecast & Market SizingContinued..

Get Full Table of Contents with Charts, Figures & Tables @https://www.databridgemarketresearch.com/toc/?dbmr=global-bio-based-itaconic-acid-market

About Us:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:

Data Bridge Market Research

Tel: +18883872818

corporatesales@databridgemarketresearch.com

Here is the original post:
Bio-Based Itaconic Acid Market 2021 | Key Findings, Trends, Market Share, and Growth Forecast | Thermo Fisher Scientific., Itaconix Corporation,...

Fully Auto Biochemistry Analyzer Market 2021-2027 Global Industry to Revenue Growth in the Coming Years NeighborWebSJ – NeighborWebSJ

Global Fully Auto Biochemistry Analyzer Market 2021-27 Abbott, Hitachi, Mindray Medical, Thermo Scientific

The research report on the Fully Auto Biochemistry Analyzer Market 2021-27 2021 is a highly professional, comprehensive and detailed assessment of the respective market that offers significant information for those who are seeking information about the global Fully Auto Biochemistry Analyzer industry. The Fully Auto Biochemistry Analyzer market report provides an in-depth specification, essential strategies, cost structure and upcoming prospects of the world Fully Auto Biochemistry Analyzer market. It also highlights the futuristic trends in the Fully Auto Biochemistry Analyzer market that will impact the marketing demand during the predicted timeframe from 2021-2027.

Request for a sample copy of this report: https://spiremarketresearch.com/report/global-fully-auto-biochemistry-analyzer-market-328349#request-sample

The global Fully Auto Biochemistry Analyzer market report encloses brief analysis on the international marketplace and meanwhile, it elaborates volume and value based on the revenue approaches made by leading firms. The report has been designed with precise as well as authenticated industrial estimations determining all the components and Fully Auto Biochemistry Analyzer market dynamics. It also includes immensely crucial and descriptive statistics related to the development and growth prospects of the whole industry. Detailed segmentation of the global Fully Auto Biochemistry Analyzer market has also been studied in this report in order to deliver profound knowledge for supplementary industrial expenditures.

Key companies covered in this report are:

RocheDanaherSiemens HealthcareAbbottHitachiMindray MedicalThermo ScientificKHBAbaxisHoriba MedicalELITechGaomi CaihongSunostikSenloSysmexUritTecom ScienceRandox LaboratoriesDiruiAdaltisRayto

Product types of the Fully Auto Biochemistry Analyzer market are:

Floor-standingBench-top

Major applications included in this report are:

HospitalResearchOthers

Geographical analysis of the Fully Auto Biochemistry Analyzer market is:

It sheds light on the competitive environment of the specific industry. With the help of quantitative and qualitative data offered in the global Fully Auto Biochemistry Analyzer market report, the industry players can easily analyze prime strategies adopted by top vendors of the Fully Auto Biochemistry Analyzer market in detail. They will also be able to plan business-oriented strategies to gain a competitive benefit in the Fully Auto Biochemistry Analyzer market.

Inquiry before buying full report of Fully Auto Biochemistry Analyzer market: https://spiremarketresearch.com/report/global-fully-auto-biochemistry-analyzer-market-328349#inquiry-for-buying

The well-established and emerging manufacturers of the global Fully Auto Biochemistry Analyzer market are studied widely taking into consideration their profiles, production value, Fully Auto Biochemistry Analyzer market share, sales growth, product specification, gross margin, profitability and other crucial parameters. This will help manufacturers to become familiar with moves of their competitors in the global Fully Auto Biochemistry Analyzer market.

Vital questions answered in the Fully Auto Biochemistry Analyzer market are:

What are distinct distribution and marketing channels? What are the strengths and weaknesses of the global Fully Auto Biochemistry Analyzer market? What are the largest competitors in the Fully Auto Biochemistry Analyzer market? What is the Fully Auto Biochemistry Analyzer market growth rate in the predicted period? What are the possible opportunities available in the Fully Auto Biochemistry Analyzer market?

Spire Market Research offers attractive discounts on customization of reports as per your Requirement. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that as you need

About Spire Market Research

Spire Market Research (https://spiremarketresearch.com//) is a leading distributor of market research report with more than 1000+ global clients. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Contact Info

Spire Market ResearchEmail [emailprotected]/Website https://spiremarketresearch.com/Address 3626 North Hall Street (Two Oak Lawn), Suite 610, Dallas, TX 75219 USA.

https://neighborwebsj.com/

Follow this link:
Fully Auto Biochemistry Analyzer Market 2021-2027 Global Industry to Revenue Growth in the Coming Years NeighborWebSJ - NeighborWebSJ

Immunomic Therapeutics’ CEO to present at the BIO CEO & Investor Digital Conference – Business Wire

ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company will present at the BIO CEO & Investor Digital Conference, February 16-18, 2021. Chief Executive Officer at ITI, Dr. Bill Hearl, will present a talk titled, ITI-1000-A Novel Immunotherapy for GBM. Dr. Hearl will discuss ITIs investigational UNiversal Intracellular Targeted Expression (UNITE) platform and its application in immuno-oncology, specifically glioblastoma multiforme (GBM). ITIs technology platform has the potential to utilize the bodys natural biochemistry to develop a broad immune response and is currently being employed in a Phase II clinical trial as a cancer immunotherapy.

Presentation details are as follows:

Who: William Hearl, Ph.D., Founder and CEO of Immunomic Therapeutics

What: ITI-1000--A Novel Immunotherapy for GBM

Where: Immunomic Therapeutics, Inc. - BIO CEO & Investor Digital Conference | BIO

About UNITE

ITIs investigational UNITE platform, or UNiversal Intracellular Targeted Expression, works by fusing target antigens with the Lysosomal Associated Membrane Protein, an endogenous protein in humans, for immune processing. In this way, ITIs vaccines (DNA or RNA) have the potential to utilize the bodys natural biochemistry to develop a broad immune response including antibody production, cytokine release and critical immunological memory. This approach could put UNITE technology at the crossroads of immunotherapies in a number of illnesses, including cancer, allergy and infectious diseases. UNITE is currently being employed in Phase II clinical trials as a cancer immunotherapy. ITI is also collaborating with academic centers and biotechnology companies to study the use of UNITE in cancer types of high mortality, including cases where there are limited treatment options like glioblastoma and acute myeloid leukemia. ITI believes that these early clinical studies may provide a proof of concept for UNITE therapy in cancer, and if successful, set the stage for future studies, including combinations in these tumor types and others. Preclinical data is currently being developed to explore whether LAMP nucleic acid constructs may amplify and activate the immune response in highly immunogenic tumor types and be used to create immune responses to tumor types that otherwise do not provoke an immune response.

About Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc. (ITI) is a privately-held, clinical stage biotechnology company pioneering the development of vaccines through its investigational proprietary technology platform, UNiversal Intracellular Targeted Expression (UNITE), which is designed to utilize the bodys natural biochemistry to develop vaccines that have the potential to generate broad immune responses. The UNITE platform has a robust history of applications in various therapeutic areas, including infectious diseases, oncology, allergy and autoimmune diseases. ITI is primarily focused on applying the UNITE platform to oncology, where it could potentially have broad applications, including targeting viral antigens, cancer antigens, neoantigens and producing antigen-derived antibodies as biologics. In early 2020, an investment of over $78M by HLB Co., LTD, a global pharmaceutical company, enabled ITI to accelerate application of its immuno-oncology platform, in particular to glioblastoma multiforme, and rapidly advance other key candidates in the pipeline, including the most recent initiative into infectious diseases with development of its vaccine candidate for COVID-19. The Company has built a large pipeline from UNITE with four oncology programs, multiple animal health programs and a SARS-CoV-2 program to prevent and treat COVID-19. ITI has entered into a significant allergy partnership with Astellas Pharma and has formed several academic collaborations with leading Immuno-oncology researchers at Duke University and the University of Florida. ITI maintains its headquarters in Rockville, Maryland. For more information, please visit http://www.immunomix.com.

The rest is here:
Immunomic Therapeutics' CEO to present at the BIO CEO & Investor Digital Conference - Business Wire

Should people who have had Covid-19 be at the back of the vaccine queue? – The Week (UK)

Matt Webster, principal lecturer in biochemistry at Anglia Ruskin University, onwhether natural antibodies reduce the need for a quick jab

A recent report from Public Health England showed that 83% of people who had had Covidwere protected from reinfection five months later. Given that 3.7 million people in the UK have had Covid, should those with antibodies be at the back of the vaccine queue?

With the current high death rate, rising case numbers, closed schools and a seemingly interminable lockdown, it is natural to look for ways to speed up the vaccination rollout. Surely those who have already had Covid and recovered can be deprioritised so that people shielding at home can receive the vaccine sooner?

Certainly, the government is not afraid of hacking the process to increase short-term vaccine coverage. The recent example of lengthening the wait for a second dose proves that. But how feasible and effective would it be to not vaccinate people who have had the virus?

First, how sure are we that those people recovered remain protected five months later? While there is no doubt that the antibodies that helped you recover from Covid will last for some time after your illness, hopefully reducing the chance of reinfection, this study was on recovered healthcare professionals, looking at whether they went on to catch Covid again.

Despite the rising case number, a lot improved in those five months, particularly in the availability of protective equipment for healthcare workers and the isolation of Covid patients in hospital. This complicates checking healthcare workers antibody-derived protection rates and the calculation for how long you may remain protected.

But cant we just check the antibodies at the test centres, sending those home that dont need their immune system trained in Covid-focused jiu-jitsu? We can definitely test for antibodies. The test has been available with a few stop-starts for some time, but critically it relies on a blood test.

Englands test-and-trace programme, which has struggled to process swab tests on the scale needed to match case numbers, would surely collapse at the request to process antibody tests for the entire UK population. Shipping, extraction, processing, testing...all while poor Mrs Jones sits in a school hall with a nurse poised with a vaccine jab waiting for the green light.

How about using the test-and-trace data to sort those that need the jab from those that dont?

While I will overlook that use of dont (antibodies are not everlasting, even if you have had Covid) the real question here is how much do you trust the accuracy of test and trace, and of peoples ability to self-declare accurately? At the start of the pandemic everyone I spoke with had had that Covid despite being untested and unable to identify any exposure other than I went on a train.

This improved with mass swab-testing, but accuracy, particularly false positives, would be an issue if used to exclude vulnerable people from the vaccine queue.

Like many things related to this pandemic, a good idea is complicated by the detail.

Vaccine deployment could be targeted more precisely if we knew how long each of us retained antibodies and had an instant test capable of estimating how much and for how long we would be protected. Given that we have neither - and the NHS is under immense pressure already -the approach of vaccinating in demographic groups currently appears to be our only option.

Matt Webster, principal lecturer in biochemistry atAnglia Ruskin University.

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read more here:
Should people who have had Covid-19 be at the back of the vaccine queue? - The Week (UK)

Biochemistry Analyzer Consumption Market Report By Application, Type, Top Companies, Growth, Regional Outlook, and Forecast to 2027 Murphy’s Hockey…

New Jersey, United States,- Biochemistry Analyzer Consumption Market Report, published by Market Research Intellect, provides an industry assessment of the Biochemistry Analyzer Consumption market covering the most important factors driving the growth of the Biochemistry Analyzer Consumption industry. Biochemistry Analyzer Consumptions latest market research report contains an extensive analysis of micro and macroeconomic indicators affecting the development of the global market in the forecast period 2020-2027.

The current trends of the Biochemistry Analyzer Consumption market, combined with broad growth opportunities, key drivers, constraints, challenges and other important aspects, are detailed in the Biochemistry Analyzer Consumption market report. Additionally, the report makes many development prospects for key players involved in the Biochemistry Analyzer Consumption industry taking into account various market dynamics.

The Global Biochemistry Analyzer Consumption Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2020 to 2027.

The latest report is the most recent study providing a 360-degree coverage of the Biochemistry Analyzer Consumption industry facing the negative economic impacts of the COVID-19 outbreak from earlier this year.

Overview of the Biochemistry Analyzer Consumption Report:

The Biochemistry Analyzer Consumption market has been broadly segmented to allow readers a deeper understanding of the different aspects and attributes of the market. The market size of new entrants and existing companies was assessed using a variety of analytical tools including SWOT analysis, investment assessment, and Porters Five Forces Analysis. Additionally, as part of the study, report authors assessed the financial position of leading companies operating in the industry. They provided important insights into gross profit margin, revenue sharing, sales volume, operating costs, individual growth rates, and many other financial metrics of these competitors.

Biochemistry Analyzer Consumption Market Report Scope

What key bits of knowledge does the Biochemistry Analyzer Consumption statistical surveying give?

Past and current income insights of the Biochemistry Analyzer Consumption market players investigated at local level. Individual profiling of significant partners. Analysis of the Biochemistry Analyzer Consumption market size based on item type and end use type. Accurate Biochemistry Analyzer Consumption market estimate in numbers and percent rates. Demand prospect of individual sections shrouded in the Biochemistry Analyzer Consumption report.

What inquiries are settled by the Biochemistry Analyzer Consumption statistical surveying?

1. What are the restrictions hindering the advancement of Biochemistry Analyzer Consumption market? 2. Why are the end shoppers getting more slanted towards elective Biochemistry Analyzer Consumption market items? 3. How is the Biochemistry Analyzer Consumption market expected to shape, in the following septennial? 4. What methodologies are being designated by the significant players of the Biochemistry Analyzer Consumption market to get an edge over the opposition? 5. What methods are being utilized by the set up players of the Biochemistry Analyzer Consumption market to remain in front of the opposition?

Why pick Market Research Intellect?

Smart dashboard to give insights regarding industry patterns. Data assortment from various organization accomplices, for example, providers, sellers, specialist co-ops, for giving legible information about the Biochemistry Analyzer Consumption market. Strict quality checking norms Data assortment, triangulation, and approval. 24/7 at your service.

Visualize Biochemistry Analyzer Consumption Market using Verified Market Intelligence:-

Verified Market Intelligence is our BI enabled platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment and Key players of your market. Present your Market Report & findings with inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us:Market Research IntellectMarket Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering customized and in-depth research studies.

Our advanced analytical research solutions, custom consulting and in-depth data analysis cover a range of industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverages. Etc

Our research studies help our clients to make superior data-driven decisions, understand market forecast, capitalize on future opportunities and optimize efficiency by working as their partner to deliver accurate and valuable information without compromise.

Having serviced over 5000+ clients, we have provided reliable market research services to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.Contact us:

Mr. Edwyne Fernandes

Market Research IntellectUS: +1 (650)-781-4080UK: +44 (753)-715-0008APAC: +61 (488)-85-9400US Toll-Free: +1 (800)-782-1768

Website https://www.marketresearchintellect.com/

Excerpt from:
Biochemistry Analyzer Consumption Market Report By Application, Type, Top Companies, Growth, Regional Outlook, and Forecast to 2027 Murphy's Hockey...

Africa’s Hit Science Show For Kids Is Coming To The U.S. – NPR

Lorraine Ololia is 10. She lives in Kampala, Uganda. And she recently came up with a new career goal.

A TV show about science, produced by teachers from her junior high school, has inspired her. She's watched an episode on computer programming, another where two young explorers visit her country's Lake Victoria to talk about wetlands and learned how to make a model of a digestive tract at home using bowls, crackers, water, food coloring, bananas and oranges.

She's even appeared on the show, making and launching a rocket with her friend Samantha.

And now she wants to pursue a career in science.

"It's boys who do all the fun stuff and sometimes a girl like me gets a little left out," she says. "But girls can be scientists and go to the moon."

The show is called N*Gen (pronounced "engine), or Next Generation Television.

N*Gen first aired on Ugandan TV in September and since then, the show, which features a dozen 35-minute episodes, has been picked up by TV networks in more than half a dozen African countries.

On Feb. 6, it will debut in North America and the Caribbean on The Africa Channel, airing every Saturday and Sunday at 6 a.m. and 9 a.m. ET.

N*Gen is the brainchild of six teachers from Clarke Junior School in Kampala and East African nonprofit Peripheral Vision International, which funds and produces it.

"Choosing a science focus for N*Gen is an absolute necessity because not only is it a neglected area, it is considered one of the hard subjects [for many students]," says Joy Kiano, a teacher who has a Ph.D. in both biochemistry and molecular biology and is a consultant with Peripheral Vision International.

The show, targeting children ages 8 to 12, looks at science through an African lens. Weekly episodes are filmed in a studio in Kampala and sometimes on location (visiting a chocolate factory for an episode about food, for example).

About Goats and Soda

Goats and Soda is NPR's global health and development blog. We tell stories of life in our changing world, focusing on low- and middle-income countries. And we keep in mind that we're all neighbors in this global village. Sign up for our weekly newsletter. Learn more about our team and coverage.

Kiano says it was important to feature African women in science. Some male teachers appear but guest scientists are mainly female. And the two main presenters, Irene Nyangoma Mugadu and Annah Komushana, are women as well: Ugandan teachers from Clarke Junior School in Kampala.

"Society expects little from girls and women," says Mugadu. "Girls need to be empowered to reach their full potential academically and explore disciplines that are mainly pursued by boys."

A team of teachers and producers in Uganda as well as Nigeria and Kenya where some segments are also filmed brainstorm ideas for episodes. For many of them, it was their first time working in TV.

The goal is to "tackle topics which are all around us" but may be unfamiliar to the audience, says Komushana. "It has also given them a chance to explore and carry out different experiments."

Episode subjects range from astrophysics to biology to the natural sciences. Presenters give short lessons on topics such as bees, robots, sounds, water and paleontology. They conduct science experiments how to make a model of an X-ray of their hand using paper and flour, for example. The instructions: Sprinkle flour over the hand on a black piece of paper to create an outline, then place 27 sticks on the paper to represent the 27 bones in the hand.

For a segment called "The Africa Teacher Challenge," teachers send in video clips of their science lessons. In one, a teacher from Tanzania gives a lesson on eating insects as a delicacy across Africa. "You may think it's strange to eat worms, but worms and insects in general are a staple for many people and they are very nutritious," says Seam Rampling Ongala from Dar es Salaam. "They contain more protein than meat and a rich source of minerals such as iron and calcium."

Educators have praised the show for prominently featuring women. Christine Kathurima, principal of Nova Pioneer Schools, an independent school network spanning preschool to secondary grades in Kenya and South Africa, describes N*Gen as "absolutely ground-breaking in the quality and the African female presenters." She is not affiliated with the show.

"I absolutely love seeing women presenters," she adds. "When I watched the show I realized that many of the educational videos that we use do not intentionally seek female hosts. Kids' singing shows and storytelling shows have a good amount of representation across the board, however when it comes to science this is a first for me."

The show's focus on African perspectives, locations and scientific discoveries has also impressed broadcasters, who say it's unlike any other science show that's appeared on African TV.

"Most often we broadcast foreign content from Western countries. However, we hope more African productions will be made for African broadcasters," says Kalumbu Lumpa, a content acquisition manager from Zambian TV network ZNBC.

Jeff Schon, CEO and co-founder of Akili Kids!, a children's learning channel based in Kenya, said the network had been screening programs such as U.S. program SciGirls, which showcases STEM-related content.

"[It is] a lovely program, but it's certainly not shot here," he says. "It is in some cases dealing with subjects that are not going to resonate here." SciGirls, he says, had a segment on shoes designed for safely walking on Minnesota's icy winter streets, for example.

N*Gen, on the other hand, puts the spotlight on Africa. "I enjoyed a recent episode we broadcast, titled 'Bones,' that had a segment on [the fossil] Turkana Boy whose bones are housed at the Kenya National Museum," he says. "The segment featured a paleontologist from the museum and the program did a great job of presenting him as a role model and inspiration for future generations of scientists."

Schon is proud to share that in Kenya, where it's been broadcast twice on weekends since Oct. 10, each episode is watched on average by 658,000 children under 14 and 642,000 adults.

The cast and producers began scripting a second N*Gen series in January with a focus on climate change-related issues. And they plan to keep filming even if the pandemic keeps kids out of the classroom.

Freelance journalist Amy Fallon has reported from Africa, Asia, Australia and the United Kingdom. She is on Twitter @amyfallon

Read more here:
Africa's Hit Science Show For Kids Is Coming To The U.S. - NPR

UTEP Fights Superbugs with $1.2 Million NIH Grant to Develop a New Way to Produce Antibiotics – Newswise

Newswise EL PASO, Texas Chu-Young Kim, Ph.D., associate professor of chemistry and biochemistry at The University of Texas at El Paso, is helping combat the threat of superbugs illnesses caused by drug-resistant bacteria by returning to nature.

His work is supported by a $1.2 million grant from the National Institutes of Health (NIH) to develop a biological method for producing new versions of current antibiotics that have become ineffective due to resistance.

Superbugs are a major problem threatening the lives and health of people worldwide. A 2019 report by the Centers for Disease Control and Prevention states that more than 2.8 million antibiotic-resistant infections occur in the United States each year, and more than 35,000 people die as a result.

Kim said that the development of new antibiotics is essential since many are rapidly becoming less useful due to resistance. Rather than attempt to create entirely new compounds, Kim and his research team are taking drugs that already exist and modifying their chemical structure so that they retain the antibacterial activity but overcome resistance.

Antibiotic drug resistance represents a real health threat, said Robert Kirken, Ph.D., dean of the College of Science. Over the past several decades we have seen little drug development in this area until recently. The work by Dr. Kim will help us stay one step ahead of these infections that kill tens of thousands of Americans each year.

Traditionally, scientists modify drug molecules using chemical methods. Penicillin is one example of a drug that has seen enhanced versions developed throughout the years. However, Kim said that most antibiotics have structures that are more complex than penicillin. Thus, using chemicals to prepare new versions of these drugs would take years and the yield would be very low, making it impractical from a commercial standpoint and unaffordable for patients.

What we are doing is, instead of chemically modifying the drug molecules as it is traditionally done, were going back to the original microorganisms that synthesize these antibiotics in the first place, Kim said. For example, penicillin is produced by a fungus and echinomycin is derived from a soil bacterium. The research team will study how nature generates these complex molecules.

Our ultimate goal is to use that knowledge to engineer microorganisms by mutating their DNA so that they produce a modified antibiotic that is effective against superbugs, Kim said. By doing it this way, we can produce very large quantities of the drug via fermentation and provide it to patients at an affordable price.

Kim and his research team of undergraduate and graduate students will focus their efforts on studying how bacteria produce a natural product antibiotic called lasalocid. This drug requires nine enzymes proteins that perform chemical transformations to work together for bacteria to synthesize the antibiotic.

Read the original here:
UTEP Fights Superbugs with $1.2 Million NIH Grant to Develop a New Way to Produce Antibiotics - Newswise